Hot Features
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company’s lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential cancer targets, including pancreatic, colon, leukemia, ovar... Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company’s lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential cancer targets, including pancreatic, colon, leukemia, ovarian, and breast cancer. Quest PharmaTech Inc. is headquartered in Edmonton, Canada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.03 | 0.03 | 0.03 | 25000 | 0.03 | CS |
| 4 | -0.001 | -3.22580645161 | 0.031 | 0.031 | 0.03 | 25000 | 0.0305 | CS |
| 12 | -0.0004 | -1.31578947368 | 0.0304 | 0.031 | 0.03 | 8358 | 0.0304997 | CS |
| 26 | 0.0167 | 125.563909774 | 0.0133 | 0.031 | 0.0133 | 5572 | 0.0304997 | CS |
| 52 | 0.0167 | 125.563909774 | 0.0133 | 0.031 | 0.0133 | 2388 | 0.0304997 | CS |
| 156 | -0.01 | -25 | 0.04 | 0.04 | 0.0133 | 9326 | 0.01775403 | CS |
| 260 | -0.048899 | -61.9767043942 | 0.078899 | 0.0848 | 0.0133 | 40504 | 0.05721296 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.